According to the RNA-seq data, among 10 adenoma patients, four samples were identified as having low CARD11 expression (CARD11−), and six samples were identified as having high CARD11 expression (CARD11+), whereas in 13 carcinoma samples, eight samples were identified as having low CARD11 expression (CARD11−) and five samples were identified as having high CARD11 expression (CARD11+). Here, CARD11 is linked to adenoma.